Drug Prices
The Push for Affected person-Centered Drug Improvement
January 10, 2022 | Julia DiFiore, PhD | Medical Analysis Scientist I | Regulatory Affairs Many…
Drug Prices
Drug Prices
Drug Prices
Maintain ’em Coming: An Overview of IND Updates
June 2, 2020 | Kathryn Tworkoski, PhD, RAC | Principal Scientific Analysis Scientist | Regulatory Affairs,…
Drug Prices
From Benchtop to Desktop: 8 Transferable Expertise Realized within the Lab that Apply to Medical Writing
October 30, 2019 | Brandi Schuster, PhD, Scientific Analysis Scientist | Medical Writing Companies So that…
Drug Prices
Eight Issues About Regulatory Medical Writing That Could Shock an Educational
August 30, 2019 | Nicole Tackmann, PhD, Scientific Analysis Scientist II | Medical Writing Companies The…
Drug Prices
Statistics in Concord: The Position of Estimands in Regulatory Writing
February 25, 2019 | Cheryl Ainslie, PhD, Medical Analysis Scientist II | Regulatory Affairs Companies ich.org…
Drug Prices
Class of 2019: Inaugural Yr of IMPACT’s Medical Writing Fellowship Program
January 28, 2019 | Laurel Kartchner, PhD, Amritha Kidiyoor, PhD, and Brandi Schuster, PhD, Medical Writing…
Drug Prices
Present Matters in Orphan Drug Growth
December 14, 2018 | Kathryn Tworkoski, PhD, RAC, Senior Medical Analysis Scientist │ Regulatory Affairs, Medical Writing, Drug…
Drug Prices
Professional Suggestions for Protocol Writing
September 28, 2018 | Kathryn Tworkoski, PhD, RAC, Senior Scientific Analysis Scientist │ Medical Writing Providers…
Drug Prices
Getting in Tune: The ICH Strategy of Harmonizing Tips
August 16, 2018 | Cheryl Ainslie, PhD, Scientific Analysis Scientist II │ Regulatory Affairs Companies Picture…
Drug Prices
Useful Ideas I Realized on the AMWA Carolinas Spring Convention
July 10, 2018 | Caroline Drucker, PhD, Medical Analysis Scientist II │ Medical Writing Companies In…
